
The unexpected alliance lobbying for Medicare to pay for new obesity drugs
Lawmakers banned coverage of obesity drugs when the Medicare’s prescription drug benefit was created in 2003.
Read The StoryInside the discoveries, personalities, and deals driving drug development. Sign up for The Readout newsletter to get the latest on biotech delivered to your inbox. And subscribe to STAT+ to access daily, market-moving coverage of the biotech sector — from startup funding to clinical trial readouts
Lawmakers banned coverage of obesity drugs when the Medicare’s prescription drug benefit was created in 2003.
Read The Story